Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Backlog of orders refers to the quantity and combined monetary value of the products which have been ordered by customers but which have not shipped yet.
Veradigm's Order Backlog for Technology (USD Mil) for the quarter that ended in Jun. 2022 was 0.00
Veradigm's Order Backlog for Technology (USD Mil) for the annual that ended in Dec. 2021 was 3,787.00
, which lower from pervious year (Dec. 2020)'s result by 6.98%.
The historical rank and industry rank for Veradigm's Order Backlog for Technology (USD Mil) or its related term are showing as below:
MDRX's Order Backlog for Technology (USD Mil) is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: * Ranked among companies with meaningful Order Backlog for Technology (USD Mil) only.
Veradigm (OTCPK:MDRX) Order Backlog for Technology (USD Mil) Explanation
The term backlog refers to a buildup of work that has not yet been completed by the company. The presence of a backlog can have positive or negative implications. For example, a rising backlog of product orders might indicate rising sales. On the other hand, companies generally want to avoid having a backlog as it could cause (or be a result of) increasing inefficiency in the production process. Likewise, a falling backlog might be a sign of lagging demand but could also be a result of improving production efficiency. Naturally, unexpected backlogs can compromise forecasts and production schedules.
Veradigm Order Backlog for Technology (USD Mil) Related Terms
Veradigm Order Backlog for Technology (USD Mil) Historical Data
* Premium members only.
The historical data trend for Veradigm's Order Backlog for Technology (USD Mil) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veradigm Order Backlog for Technology (USD Mil) Chart
MDRX vs WEAV, PHR, SOPH: Order Backlog for Technology (USD Mil) Comparison
For the Health Information Services subindustry, Veradigm's Order Backlog for Technology (USD Mil), along with its competitors' market caps and Order Backlog for Technology (USD Mil) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
What does a Order Backlog for Technology (USD Mil) of 0.00 mean?
Veradigm (MDRX) has a Order Backlog for Technology (USD Mil) of 0.00 as of Jun. 2022. Backlog of orders refers to the quantity and combined monetary value of the products which have been ordered by customers but which have not shipped yet. View historical data on Veradigm and its competitors.
Is Veradigm's Order Backlog for Technology (USD Mil) too high?
Veradigm's current Order Backlog for Technology (USD Mil) is 0.00. Overall, Veradigm has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Veradigm's Order Backlog for Technology (USD Mil) compare to WEAV and PHR?
Veradigm's Order Backlog for Technology (USD Mil) of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Order Backlog for Technology (USD Mil) for a Healthcare Providers & Services company?
A good Order Backlog for Technology (USD Mil) depends on the Healthcare Providers & Services industry context. However, Order Backlog for Technology (USD Mil) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Order Backlog for Technology (USD Mil) mean?
A high Order Backlog for Technology (USD Mil) can signal that a stock is expensive relative to its fundamentals. Backlog of orders refers to the quantity and combined monetary value of the products which have been ordered by customers but which have not shipped yet. View historical data on Veradigm and its competitors. Veradigm's current Order Backlog for Technology (USD Mil) is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradigm stock overvalued right now?
Veradigm (MDRX) has a current Order Backlog for Technology (USD Mil) of 0.00. The current Order Backlog for Technology (USD Mil) is 0.00. Veradigm's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Order Backlog for Technology (USD Mil) calculated?
Order Backlog for Technology (USD Mil) is calculated from a company's financial statements. For Veradigm (MDRX), the current Order Backlog for Technology (USD Mil) is 0.00 as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Veradigm Inc together with its subsidiaries, is a healthcare software-as-a-service (SaaS) technology, data and analytics company spanning the three pillars of healthcare: Provider, Payer and Life Science. Its Provider segment represents the source of revenue, followed by the Payer segment, with the Life Science segment contributing a comparatively smaller portion. Its portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI) enhanced solutions to help improve health outcomes and reduce costs.
23GF Score
Get the complete analysis for MDRX
Order Backlog for Technology (USD Mil) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDRX has been successfully added to your 
